Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDA XII: Vitamin B Supplementation in Cardiovascular Surgery
NCT07348328Not yet recruiting
- Sponsor
- Nanjing Medical University
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of compound vitamin B tablet in major adverse cardiovascular events (MACE) (2 arms), sponsored by Nanjing Medical University. Primary endpoint: Major Adverse Cardiovascular Events at 6 months. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
compound vitamin B tablet
03
Conditions
major adverse cardiovascular events (MACE)
Beyond the preview
Go deeper on NCT07348328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07348328.